Text Size

Vitamin d Levels and Coronary Catheterization

This study has been completed.
Sponsor:
Information provided by:
Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier:
NCT00749541
First received: September 7, 2008
Last updated: December 15, 2010
Last verified: September 2008
History of Changes
  Purpose

decreased vitamin d levels are associated with increased inflammatory markers,and renin angiotensin levels.

decreased levels were also found to be connected to increased cardiovascular mortality.

we therefore hypothesise that in patients with pathological results of coronary catheterization we will find decreased levels of 25 hydroxy vitamin d.

we will examine patients undergoing elective coronary catheterization and compare two groups: those with normal results and those with pathological results.


Condition
Vitamin D Deficiency

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: 25 Hydroxy Vitamin d Levels in Patients Undergoing an Elective Coronary Catheterization

Resource links provided by NLM:

MedlinePlus related topics: Vitamin D
Drug Information available for: Vitamin D
U.S. FDA Resources

Further study details as provided by Assaf-Harofeh Medical Center:

Biospecimen Retention:   Samples Without DNA

blood samples


Estimated Enrollment: 100
Study Start Date: November 2008
Study Completion Date: August 2009
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
1normal catheter.
abnormal catheter.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

patients undergoing an elective coronary catheterization over the age of 18.

Criteria

Inclusion Criteria:age

  • >18 years,
  • no known ihd

Exclusion Criteria:

  • renal failure ,
  • medications including vitamin d, calcium ,phosphate
  • hyper or hypoparathyroidism,
  • abnormal calcium or phosphate values,
  • known pathological coronary catheterization.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00749541

Locations
Israel
Assaf Harofeh Mc
Zerifin, Israel
Sponsors and Collaborators
Assaf-Harofeh Medical Center
Investigators
Principal Investigator: renana shor, md assaf harofeh mc
  More Information

No publications provided

Responsible Party: dr. renana shor, assaf harofeh medical center internal medicine a
ClinicalTrials.gov Identifier: NCT00749541     History of Changes
Other Study ID Numbers: vitamin d
Study First Received: September 7, 2008
Last Updated: December 15, 2010
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Assaf-Harofeh Medical Center:
vitamin d coronary catheterization

Additional relevant MeSH terms:
Vitamin D Deficiency
Avitaminosis
Deficiency Diseases
Malnutrition
Nutrition Disorders
Vitamin D
Ergocalciferols
 Vitamins
Bone Density Conservation Agents
Physiological Effects of Drugs
Pharmacologic Actions
Micronutrients
Growth Substances

ClinicalTrials.gov processed this record on May 22, 2013